Table of Content

1 Endoparasiticide Market Overview
1.1 Product Overview and Scope of Endoparasiticide
1.2 Endoparasiticide Segment by Type
1.2.1 Global Endoparasiticide Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Ear Tags
1.2.3 Tablets
1.2.4 Injectables
1.2.5 Feed Additives
1.3 Endoparasiticide Segment by Application
1.3.1 Endoparasiticide Sales Comparison by Application: (2021-2027)
1.3.2 Veterinary Hospitals or Clinics
1.3.3 Animal Farms
1.3.4 Home Care Settings
1.4 Global Endoparasiticide Market Size Estimates and Forecasts
1.4.1 Global Endoparasiticide Revenue 2016-2027
1.4.2 Global Endoparasiticide Sales 2016-2027
1.4.3 Endoparasiticide Market Size by Region: 2016 Versus 2021 Versus 2027

2 Endoparasiticide Market Competition by Manufacturers
2.1 Global Endoparasiticide Sales Market Share by Manufacturers (2016-2021)
2.2 Global Endoparasiticide Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Endoparasiticide Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Endoparasiticide Manufacturing Sites, Area Served, Product Type
2.5 Endoparasiticide Market Competitive Situation and Trends
2.5.1 Endoparasiticide Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Endoparasiticide Players Market Share by Revenue
2.5.3 Global Endoparasiticide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Endoparasiticide Retrospective Market Scenario by Region
3.1 Global Endoparasiticide Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Endoparasiticide Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Endoparasiticide Market Facts & Figures by Country
3.3.1 North America Endoparasiticide Sales by Country
3.3.2 North America Endoparasiticide Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Endoparasiticide Market Facts & Figures by Country
3.4.1 Europe Endoparasiticide Sales by Country
3.4.2 Europe Endoparasiticide Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Endoparasiticide Market Facts & Figures by Region
3.5.1 Asia Pacific Endoparasiticide Sales by Region
3.5.2 Asia Pacific Endoparasiticide Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Endoparasiticide Market Facts & Figures by Country
3.6.1 Latin America Endoparasiticide Sales by Country
3.6.2 Latin America Endoparasiticide Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Endoparasiticide Market Facts & Figures by Country
3.7.1 Middle East and Africa Endoparasiticide Sales by Country
3.7.2 Middle East and Africa Endoparasiticide Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Endoparasiticide Historic Market Analysis by Type
4.1 Global Endoparasiticide Sales Market Share by Type (2016-2021)
4.2 Global Endoparasiticide Revenue Market Share by Type (2016-2021)
4.3 Global Endoparasiticide Price by Type (2016-2021)

5 Global Endoparasiticide Historic Market Analysis by Application
5.1 Global Endoparasiticide Sales Market Share by Application (2016-2021)
5.2 Global Endoparasiticide Revenue Market Share by Application (2016-2021)
5.3 Global Endoparasiticide Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Boehringer Ingelheim Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Elanco
6.2.1 Elanco Corporation Information
6.2.2 Elanco Description and Business Overview
6.2.3 Elanco Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Elanco Product Portfolio
6.2.5 Elanco Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Corporation Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Zoetis Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Virbac Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Novartis AG Product Portfolio
6.6.5 Novartis AG Recent Developments/Updates
6.7 Ceva Sante Animlae
6.6.1 Ceva Sante Animlae Corporation Information
6.6.2 Ceva Sante Animlae Description and Business Overview
6.6.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ceva Sante Animlae Product Portfolio
6.7.5 Ceva Sante Animlae Recent Developments/Updates
6.8 Bayer AG
6.8.1 Bayer AG Corporation Information
6.8.2 Bayer AG Description and Business Overview
6.8.3 Bayer AG Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bayer AG Product Portfolio
6.8.5 Bayer AG Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Eli Lilly Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Vetoquinol
6.10.1 Vetoquinol Corporation Information
6.10.2 Vetoquinol Description and Business Overview
6.10.3 Vetoquinol Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Vetoquinol Product Portfolio
6.10.5 Vetoquinol Recent Developments/Updates

7 Endoparasiticide Manufacturing Cost Analysis
7.1 Endoparasiticide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Endoparasiticide
7.4 Endoparasiticide Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Endoparasiticide Distributors List
8.3 Endoparasiticide Customers

9 Endoparasiticide Market Dynamics
9.1 Endoparasiticide Industry Trends
9.2 Endoparasiticide Growth Drivers
9.3 Endoparasiticide Market Challenges
9.4 Endoparasiticide Market Restraints

10 Global Market Forecast
10.1 Endoparasiticide Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Endoparasiticide by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Endoparasiticide by Type (2022-2027)
10.2 Endoparasiticide Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Endoparasiticide by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Endoparasiticide by Application (2022-2027)
10.3 Endoparasiticide Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Endoparasiticide by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Endoparasiticide by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Endoparasiticide Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Endoparasiticide Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Endoparasiticide Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Endoparasiticide Covered in This Study
Table 5. Global Endoparasiticide Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Endoparasiticide Sales Share by Manufacturers (2016-2021)
Table 7. Global Endoparasiticide Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Endoparasiticide Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Endoparasiticide Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Endoparasiticide Manufacturing Sites and Area Served
Table 11. Manufacturers Endoparasiticide Product Type
Table 12. Global Endoparasiticide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Endoparasiticide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endoparasiticide as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Endoparasiticide Sales by Region (2016-2021) & (K Units)
Table 16. Global Endoparasiticide Sales Market Share by Region (2016-2021)
Table 17. Global Endoparasiticide Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Endoparasiticide Sales by Country (2016-2021) & (K Units)
Table 19. North America Endoparasiticide Sales Market Share by Country (2016-2021)
Table 20. North America Endoparasiticide Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Endoparasiticide Revenue Market Share by Country (2016-2021)
Table 22. Europe Endoparasiticide Sales by Country (2016-2021) & (K Units)
Table 23. Europe Endoparasiticide Sales Market Share by Country (2016-2021)
Table 24. Europe Endoparasiticide Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Endoparasiticide Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Endoparasiticide Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Endoparasiticide Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Endoparasiticide Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Endoparasiticide Revenue Market Share by Region (2016-2021)
Table 30. Latin America Endoparasiticide Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Endoparasiticide Sales Market Share by Country (2016-2021)
Table 32. Latin America Endoparasiticide Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Endoparasiticide Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Endoparasiticide Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Endoparasiticide Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Endoparasiticide Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Endoparasiticide Revenue Market Share by Country (2016-2021)
Table 38. Global Endoparasiticide Sales (K Units) by Type (2016-2021)
Table 39. Global Endoparasiticide Sales Market Share by Type (2016-2021)
Table 40. Global Endoparasiticide Revenue (Million US$) by Type (2016-2021)
Table 41. Global Endoparasiticide Revenue Share by Type (2016-2021)
Table 42. Global Endoparasiticide Price (US$/Unit) by Type (2016-2021)
Table 43. Global Endoparasiticide Sales (K Units) by Application (2016-2021)
Table 44. Global Endoparasiticide Sales Market Share by Application (2016-2021)
Table 45. Global Endoparasiticide Revenue (Million US$) by Application (2016-2021)
Table 46. Global Endoparasiticide Revenue Share by Application (2016-2021)
Table 47. Global Endoparasiticide Price (US$/Unit) by Application (2016-2021)
Table 48. Boehringer Ingelheim Corporation Information
Table 49. Boehringer Ingelheim Description and Business Overview
Table 50. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Boehringer Ingelheim Endoparasiticide Product
Table 52. Boehringer Ingelheim Recent Developments/Updates
Table 53. Elanco Corporation Information
Table 54. Elanco Description and Business Overview
Table 55. Elanco Endoparasiticide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Elanco Endoparasiticide Product
Table 57. Elanco Recent Developments/Updates
Table 58. Zoetis Corporation Information
Table 59. Zoetis Description and Business Overview
Table 60. Zoetis Endoparasiticide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Zoetis Endoparasiticide Product
Table 62. Zoetis Recent Developments/Updates
Table 63. Merck Corporation Information
Table 64. Merck Description and Business Overview
Table 65. Merck Endoparasiticide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Merck Endoparasiticide Product
Table 67. Merck Recent Developments/Updates
Table 68. Virbac Corporation Information
Table 69. Virbac Description and Business Overview
Table 70. Virbac Endoparasiticide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Virbac Endoparasiticide Product
Table 72. Virbac Recent Developments/Updates
Table 73. Novartis AG Corporation Information
Table 74. Novartis AG Description and Business Overview
Table 75. Novartis AG Endoparasiticide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Novartis AG Endoparasiticide Product
Table 77. Novartis AG Recent Developments/Updates
Table 78. Ceva Sante Animlae Corporation Information
Table 79. Ceva Sante Animlae Description and Business Overview
Table 80. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Ceva Sante Animlae Endoparasiticide Product
Table 82. Ceva Sante Animlae Recent Developments/Updates
Table 83. Bayer AG Corporation Information
Table 84. Bayer AG Description and Business Overview
Table 85. Bayer AG Endoparasiticide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Bayer AG Endoparasiticide Product
Table 87. Bayer AG Recent Developments/Updates
Table 88. Eli Lilly Corporation Information
Table 89. Eli Lilly Description and Business Overview
Table 90. Eli Lilly Endoparasiticide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Eli Lilly Endoparasiticide Product
Table 92. Eli Lilly Recent Developments/Updates
Table 93. Vetoquinol Corporation Information
Table 94. Vetoquinol Description and Business Overview
Table 95. Vetoquinol Endoparasiticide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Vetoquinol Endoparasiticide Product
Table 97. Vetoquinol Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Endoparasiticide Distributors List
Table 101. Endoparasiticide Customers List
Table 102. Endoparasiticide Market Trends
Table 103. Endoparasiticide Growth Drivers
Table 104. Endoparasiticide Market Restraints
Table 105. Global Endoparasiticide Sales Forecast by Type (2022-2027) & (K Units)
Table 106. Global Endoparasiticide Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Endoparasiticide Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Endoparasiticide Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Endoparasiticide Sales Forecast by Application (2022-2027) & (K Units)
Table 110. Global Endoparasiticide Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Endoparasiticide Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Endoparasiticide Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Endoparasiticide Sales Forecast by Region (2022-2027) & (K Units)
Table 114. Global Endoparasiticide Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Endoparasiticide Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Endoparasiticide Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Endoparasiticide
Figure 2. Global Endoparasiticide Market Share by Type in 2020 & 2027
Figure 3. Ear Tags Product Picture
Figure 4. Tablets Product Picture
Figure 5. Injectables Product Picture
Figure 6. Feed Additives Product Picture
Figure 7. Global Endoparasiticide Market Share by Application in 2020 & 2027
Figure 8. Veterinary Hospitals or Clinics
Figure 9. Animal Farms
Figure 10. Home Care Settings
Figure 11. Global Endoparasiticide Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Endoparasiticide Market Size 2016-2027 (US$ Million)
Figure 13. Global Endoparasiticide Sales 2016-2027 (K Units)
Figure 14. Global Endoparasiticide Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Endoparasiticide Sales Share by Manufacturers in 2020
Figure 16. Global Endoparasiticide Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Endoparasiticide Players: Market Share by Revenue in 2020
Figure 18. Endoparasiticide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Endoparasiticide Sales Market Share by Region (2016-2021)
Figure 20. Global Endoparasiticide Sales Market Share by Region in 2020
Figure 21. Global Endoparasiticide Revenue Market Share by Region (2016-2021)
Figure 22. Global Endoparasiticide Revenue Market Share by Region in 2020
Figure 23. U.S. Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Endoparasiticide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Endoparasiticide by Type (2016-2021)
Figure 48. Sales Market Share of Endoparasiticide by Application (2016-2021)
Figure 49. Sales Market Share of Endoparasiticide by Application in 2020
Figure 50. Revenue Share of Endoparasiticide by Application (2016-2021)
Figure 51. Revenue Share of Endoparasiticide by Application in 2020
Figure 52. Manufacturing Cost Structure of Endoparasiticide
Figure 53. Manufacturing Process Analysis of Endoparasiticide
Figure 54. Endoparasiticide Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed